Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NPI 1063460970
NPI deactivated

1063460970

1063460970 was paid $827K by Medicaid between Jan 2018 and Nov 2023, across 31 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.

33Billing provider info1063460970
33aNPI1063460970
33bProvider type—
28Total paid$827K
24GClaims38,838
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2023
Box 24A · Dates of service

Paid by month

$0$10K$20K$30K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20184,227$170K
20194,091$189K
20202,996$141K
20217,287$148K
202212,040$157K
20238,197$22K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 53% 6,322 5,701 $434K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 27% 4,140 3,739 $223K
99199 Unlisted special service, procedure or report 8.4% 21,264 20,371 $69K
90460 Immunization administration through 18 years of age via any route, first or only component 2.9% 617 583 $24K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 1.8% 793 746 $14K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 1.6% 146 137 $13K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 1.3% 104 94 $11K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 125 116 $8K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 245 234 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 335 148 $4K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 577 520 $4K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 233 219 $3K
19 more codes
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 98 $3K
90686 <1% 767 $3K
90472 Immunization administration, each additional vaccine (list separately) <1% 75 $2K
36415 Collection of venous blood by venipuncture <1% 773 $1K
99442 <1% 32 $1K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 12 $1K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 28 $1K
90674 <1% 133 $537.01
92551 <1% 803 $319.34
90461 <1% 30 $267.06
99173 <1% 854 $252.72
83036 Hemoglobin; glycosylated (A1C) <1% 29 $201.12
81003 <1% 92 $138.61
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 0% 12 $0.00
G8541 Functional outcome assessment using a standardized tool not documented, reason not given 0% 72 $0.00
G8482 Influenza immunization administered or previously received 0% 17 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 58 $0.00
90670 0% 19 $0.00
G8732 No documentation of pain assessment, reason not given 0% 33 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.